Related Experiment Video
Updated: Dec 9, 2025
07:35
Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
2.2K
Clenbuterol-Induced Myocarditis: A Case Report
Natassja Moriarty1, Nadeem Attar2
1Department of Medicine, Furness General Hospital, Barrow-in-Furness, United Kingdom.
European Journal of Case Reports in Internal Medicine
|September 10, 2020
Summary
This case study highlights a bodybuilder who developed myocarditis from clenbuterol. Discontinuation of the drug and conservative management led to recovery, underscoring clenbuterol
Area of Science:
- Cardiology
- Sports Medicine
- Toxicology
Background:
- Clenbuterol, a beta-2 agonist, is used in veterinary medicine.
- It is illegally marketed as a weight loss and performance-enhancing supplement.
- Its anabolic properties make it popular among athletes and bodybuilders.
Purpose of the Study:
- To report a case of myocarditis linked to clenbuterol use.
- To emphasize the adverse cardiovascular effects of clenbuterol.
- To advocate for stricter regulations on its illegal distribution.
Main Methods:
- Case report of a 22-year-old male bodybuilder.
- Diagnosis of myocarditis secondary to clenbuterol ingestion.
- Conservative management including drug cessation and medical therapy.
Main Results:
- The patient was diagnosed with myocarditis.
- Management involved discontinuing clenbuterol and using dual anti-platelets, beta-blockers, and nitrates.
- The patient's condition improved with conservative treatment.
Conclusions:
- Clenbuterol misuse can lead to significant myocardial injury.
- Adverse effects underscore the risks associated with its illicit use.
- Tighter regulations are needed to prevent illegal distribution and protect public health.
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
146
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
146
01:21Myocarditis I: Introduction
227
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
227
01:14Myocarditis III: Medical Management
95
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
95
01:22Myocarditis IV: Nursing Management
134
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
134
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
236
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
236
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
243
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
243